Eli Lilly Archives

Healthcare Industry News Weekly Wrap-Up: March 7, 2024

// Biotech and Pharma Therapeutics RSV vaccines may raise risk of Guillain-Barré syndrome, FDA preliminary analysis finds March 4, 2024 / RSV / Pfizer / GSK / Arexvy After decades of research into respiratory syncytial virus (RSV), Pfizer and GSK’s...

March 7, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: February 29, 2024

// Biotech and Pharma Therapeutics Boehringer Ingelheim’s Liver Drug Data Position It for MASH Clash With Eli Lilly February 26, 2024 / Boehringer Ingelheim / Liver / New Drug / MASH / Eli Lilly Preliminary Phase 2 results show 83%...

February 29, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: February 22, 2024

// Biotech and Pharma Therapeutics Phage therapy: Researchers sharpen another arrow in the quiver against antibiotic resistance February 20, 2024 / Antibiotic Resistance / New Drug “It just got so frustrating over the years because we couldn’t find the source,...

February 22, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: February 9, 2024

// Biotech and Pharma Therapeutics BridgeBio sells partial rights to dwarfism drug for $100M February 7, 2024 / BridgeBio / Kyowa Kirin / BioMarin Achondroplasia is the most common form of dwarfism and is caused by alterations to a gene...

February 9, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: January 26, 2024

// Biotech and Pharma Therapeutics Lilly gene therapy finding puts focus on hearing loss treatment pipeline January 24, 2024 / Eli Lilly / Gene Therapy / Drug Target / Hearing loss An 11-year-old boy who was born deaf can hear...

January 26, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: January 19, 2024

// Biotech and Pharma Therapeutics Kyverna sets plans for IPO in test of biotech enthusiasm January 17, 2024 / Kyverna / IPO / Startup More than two years after the bottom fell out for biotech stocks, the market for IPOs...

January 19, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: January 12, 2024

// Biotech and Pharma Therapeutics CRISPR pioneer Doudna allies with Danaher for gene editing center targeting rare disease and beyond January 9, 2024 / Jennifer Doudna / CRISPR / Danaher / Gene Editing CRISPR pioneer Jennifer Doudna, Ph.D., looks set...

January 12, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: December 22, 2023

// Biotech and Pharma Therapeutics Tome Biosciences debuts with $213M and a new way to edit the genome December 12, 2023 / Tome Biosciences / Gene Editing / DNA / Startup Biotechnology startup Tome Biosciences emerged from stealth on Tuesday...

December 22, 2023

Year In Review

Healthcare Industry News 2023 Year in Review: Diabetes

// January In January, California sued insulin makers and PBMs over alleged price collusion. Oramed’s oral insulin failed in a phase 3 trial. TheracosBio’s Brenzavvy got FDA approval for diabetes. Eli Lilly invested $450 million in diabetes drug production. Claiming...

December 20, 2023

Year In Review

Healthcare Industry News 2023 Year in Review: Obesity

// January In January, the American Academy of Pediatrics recommended weight-loss drugs for kids aged 12+. Eli Lilly’s tirzepatide might become a top-selling drug, but its high cost and side effects are concerning. These drugs can make users look older....

December 19, 2023

1 2 … 6 7

Tag: Eli Lilly

Healthcare Industry News Weekly Wrap-Up: March 7, 2024

Healthcare Industry News Weekly Wrap-Up: February 29, 2024

Healthcare Industry News Weekly Wrap-Up: February 22, 2024

Healthcare Industry News Weekly Wrap-Up: February 9, 2024

Healthcare Industry News Weekly Wrap-Up: January 26, 2024

Healthcare Industry News Weekly Wrap-Up: January 19, 2024

Healthcare Industry News Weekly Wrap-Up: January 12, 2024

Healthcare Industry News Weekly Wrap-Up: December 22, 2023

Healthcare Industry News 2023 Year in Review: Diabetes

Healthcare Industry News 2023 Year in Review: Obesity

Contact Us

Vault Bioventures HQ

Maximize Innovation

Strategic Clarity

Strategy⁺

About Vault

Tag: Eli Lilly

Contact Us

Vault Bioventures HQ

Maximize Innovation

Strategic Clarity

Strategy+

About Vault

Strategy⁺